Medical Surveillance

Why Medical Surveillance Matters
Engineering controls, administrative controls, and PPE are designed to keep exposures below harmful levels, but no control system is perfect. Medical surveillance is the safety net that answers a critical question: Are our controls actually protecting people? It detects early, often reversible, health effects before they become disabling disease, verifies that exposure monitoring results translate into real-world protection, and generates data that can reveal a failing control, an unrecognized hazard, or a susceptible worker. For the ASP exam, medical surveillance appears repeatedly because it is embedded in dozens of OSHA substance-specific standards, it links industrial hygiene to occupational medicine, and it carries specific numeric triggers, recordkeeping rules, and legal obligations that lend themselves to test questions.

What Medical Surveillance Is
Medical surveillance is the systematic, ongoing collection, analysis, and interpretation of health data on workers exposed (or potentially exposed) to occupational hazards, for the purpose of preventing disease and evaluating the effectiveness of exposure controls. Key distinctions you must know:
• Medical screening focuses on the individual: tests are given to detect early disease or adverse effects in a particular worker so that intervention can occur.
• Medical surveillance focuses on the population: results from many workers are aggregated and trended to detect patterns, clusters, or sentinel health events that indicate a workplace problem.
• Biological monitoring measures the chemical, its metabolite, or a biochemical effect in a biological specimen (blood, urine, exhaled air) to estimate the dose absorbed by all routes. ACGIH publishes Biological Exposure Indices (BEIs) as reference values. Examples: blood lead, urinary mandelic acid for styrene, carboxyhemoglobin for carbon monoxide, urinary phenol or S-phenylmercapturic acid for benzene, cholinesterase activity for organophosphate pesticides.
• Exposure (environmental) monitoring measures the hazard in the workplace air or on surfaces; it estimates external exposure, not dose.
Medical surveillance is a form of secondary prevention: it does not prevent exposure (primary prevention), it detects effects early. It is never a substitute for exposure control and sits outside the hierarchy of controls.

Core Components of a Medical Surveillance Program
1. Hazard identification and population definition. Determine which agents (chemical, physical, biological, ergonomic) are present and which workers meet the exposure trigger. Triggers are usually tied to an action level (commonly one-half the PEL) or a specified duration of exposure (frequently 30 or more days per year).
2. Baseline (preplacement) examination. Performed before or shortly after assignment to establish the reference point for future comparison and to identify pre-existing conditions that could increase susceptibility (for example, a baseline audiogram, baseline spirometry, or baseline blood lead). Under the ADA, medical inquiries must occur only after a conditional offer of employment and must be job-related.
3. Periodic examinations. Repeated at intervals specified by the standard or determined by the physician (often annually; some standards allow biennial exams or every three years). Content typically includes a work and medical history, targeted physical examination, and specific tests such as chest radiograph, pulmonary function testing, audiometry, blood chemistry, or biological monitoring.
4. Episodic or event-triggered examinations. Provided after an emergency release, an overexposure, a needlestick, signs or symptoms of exposure, or upon employee request.
5. Termination (exit) examination. Required by several standards (such as HAZWOPER and asbestos) to document health status at the end of exposure.
6. Physician or Licensed Health Care Professional (PLHCP) written opinion. The PLHCP provides the employer a written opinion that is limited to occupationally pertinent findings: whether the employee has a condition that places them at increased risk, any recommended limitations on exposure or PPE (especially respirator use), and a statement that the employee was informed of the results. Specific diagnoses unrelated to occupational exposure are not disclosed to the employer; the employee receives the full results.
7. Data analysis and feedback. Aggregate results are trended, compared against exposure monitoring, and used to adjust controls. A sentinel health event (occupational) is a disease, disability, or death that is work-related and signals that prevention has failed.
8. Recordkeeping and access. Under 29 CFR 1910.1020 (Access to Employee Exposure and Medical Records), medical records are retained for the duration of employment plus 30 years; exposure records are kept for 30 years. Employees and designated representatives have access within 15 working days. Analyses using medical records must have personal identifiers removed before access by others. Medical confidentiality is governed by professional ethics and, where applicable, HIPAA and the ADA.

How It Works in Practice: Program Design Principles
• Target the test to the hazard. Choose tests with adequate sensitivity (ability to detect true cases) and specificity (ability to exclude non-cases), that detect effects at a reversible stage, and that are acceptable, safe, and cost-effective. A good surveillance test detects a preclinical effect for which an effective intervention exists.
• Use the right biological marker. Markers of exposure (blood lead), markers of effect (zinc protoporphyrin, decreased cholinesterase, hearing threshold shift), and markers of susceptibility (genetic traits) serve different purposes. Timing of sample collection matters because of biological half-lives: end-of-shift, end-of-workweek, or prior-to-shift sampling is specified for different BEIs.
• Employer obligations. Exams must be provided at no cost to the employee, at a reasonable time and place, by or under the supervision of a licensed physician or PLHCP, and the employer must give the PLHCP a description of duties, exposure levels, PPE used, and prior medical information.
• Medical removal protection (MRP). Certain standards (lead, cadmium, benzene, formaldehyde, methylene chloride) require temporary removal from exposure when biological or medical criteria are met, with maintenance of earnings, seniority, and benefits (generally up to 18 months). MRP is what makes workers willing to participate honestly.
• Integration. Surveillance data should feed back to the industrial hygienist. An unexpected rise in blood lead levels across a department, or a cluster of standard threshold shifts in one area, is an exposure-control failure until proven otherwise.

Key OSHA Standards and Their Surveillance Provisions (High-Yield)
• Occupational Noise Exposure (1910.95): Audiometric testing required when the 8-hour TWA is at or above the 85 dBA action level. Baseline audiogram within 6 months of first exposure (one year if using mobile test van, with hearing protection worn in the interim), preceded by 14 hours without workplace noise. Annual audiograms compared to baseline. A Standard Threshold Shift (STS) is an average change of 10 dB or more at 2000, 3000, and 4000 Hz in either ear. STS becomes recordable on the OSHA 300 Log when the total hearing level is 25 dB or more above audiometric zero at those frequencies. Audiometric records kept for duration of employment; noise exposure records for 2 years.
• Respiratory Protection (1910.134): A medical evaluation (questionnaire in Appendix C or an exam) by a PLHCP is required before fit testing and first use. Follow-up evaluations as medically indicated or when conditions change; no fixed annual requirement.
• Lead, general industry (1910.1025): Surveillance for workers exposed at or above the action level of 30 micrograms per cubic meter for more than 30 days per year. Blood lead and zinc protoporphyrin at least every 6 months; every 2 months if blood lead is 40 micrograms per deciliter or greater. Medical removal at 60 micrograms per deciliter or an average of the last three tests at 50 or greater; return when below 40. (Construction lead, 1926.62: removal at 50.)
• Asbestos (1910.1001): Exams for employees exposed at or above the PEL or excursion limit, including history, physical exam, pulmonary function testing, and a standardized respiratory questionnaire; chest X-ray at physician discretion. Termination exam required. Records kept for employment plus 30 years.
• Benzene (1910.1028): Surveillance at or above the 0.5 ppm action level for 30 or more days per year, with complete blood count and differential; MRP for abnormal hematology.
• Cadmium (1910.1027): Biological monitoring of cadmium in urine, cadmium in blood, and beta-2 microglobulin in urine (kidney effect marker). MRP provisions.
• Respirable Crystalline Silica (1910.1053): Exams for employees exposed at or above the action level of 25 micrograms per cubic meter for 30 or more days per year; baseline then every 3 years; includes chest X-ray read by a NIOSH-certified B reader, spirometry, and TB testing at baseline.
• Hexavalent Chromium (1910.1026): Surveillance for exposure at or above the action level for 30 or more days per year, after emergency exposure, or when signs or symptoms appear; annual exams.
• HAZWOPER (1910.120): Surveillance for workers exposed at or above PELs for 30 or more days per year, those who wear a respirator 30 or more days per year, hazmat team members, and those with exposure-related symptoms. Exams at baseline, at least every 12 months (every 2 years if the physician agrees), at termination, and after exposure incidents.
• Bloodborne Pathogens (1910.1030): Hepatitis B vaccination offered within 10 working days of assignment at no cost (declination form if refused); post-exposure evaluation and follow-up including source testing, baseline and follow-up serology, and counseling. Records kept employment plus 30 years.
• Formaldehyde (1910.1048), Methylene Chloride (1910.1052), Ethylene Oxide (1910.1047), Cotton Dust (1910.1043), Acrylonitrile, Vinyl Chloride, Arsenic and others each contain similar structures: exposure trigger, baseline and periodic exams, PLHCP written opinion, recordkeeping.
Also recognize non-OSHA surveillance frameworks: DOT/FMCSA driver medical certification, NIOSH Coal Workers Health Surveillance Program, and ACGIH BEIs as guidance values rather than enforceable limits.

Common Surveillance Tests and What They Detect
• Spirometry (pulmonary function testing): FVC, FEV1, FEV1/FVC ratio. Obstructive patterns (reduced ratio) suggest asthma or COPD; restrictive patterns (reduced FVC with normal ratio) suggest fibrotic diseases such as asbestosis or silicosis. Technicians should be NIOSH-approved course trained.
• Chest radiography with ILO classification by a B reader for pneumoconioses.
• Audiometry at 500, 1000, 2000, 3000, 4000, and 6000 Hz (8000 Hz often added). Noise-induced hearing loss typically shows a notch at 4000 Hz.
• Blood tests: blood lead, CBC for benzene, liver function for solvents, cholinesterase for organophosphates and carbamates, carboxyhemoglobin for CO.
• Urinalysis: urinary metals, metabolites, protein and beta-2 microglobulin for renal effects.
• Nerve conduction and symptom surveys for ergonomic and neurotoxic hazards.
• Vision and musculoskeletal screening for job-specific fitness.

Epidemiologic and Statistical Concepts Linked to Surveillance
Exam questions often test the vocabulary that surrounds surveillance data:
• Incidence is the rate of new cases over a period; prevalence is the proportion of existing cases at a point in time.
• Sensitivity = true positives divided by all who have the condition; specificity = true negatives divided by all who do not. A screening test with low specificity produces many false positives, leading to unnecessary follow-up.
• Positive predictive value depends heavily on prevalence; in low-prevalence working populations even good tests yield many false positives.
• Healthy worker effect: employed populations appear healthier than the general public, which can mask true occupational effects in surveillance comparisons.
• Latency: many occupational diseases (mesothelioma, silicosis, cancers) appear decades after exposure, which is why records must be retained for 30 years and why surveillance alone cannot be the control strategy.

Ethical and Legal Considerations
• Participation is generally a condition of working in the covered job, but the employee owns the detailed results; the employer receives only the written opinion.
• Results may not be used to discriminate; the ADA restricts medical inquiries and requires that fitness determinations be job-related and consistent with business necessity.
• Genetic information is protected under GINA; genetic susceptibility screening in employment is highly restricted.
• Surveillance findings that reveal a hazard create a duty to act, both legally (General Duty Clause) and ethically (BCSP Code of Ethics: hold paramount the safety and health of people).

Exam Tips: Answering Questions on Medical Surveillance
1. Classify the question first. Decide whether the item is asking about medical surveillance (population trends, program design), medical screening (individual case finding), biological monitoring (dose in the body), or exposure monitoring (air concentrations). Distractors frequently swap these terms. If the question mentions blood, urine, or exhaled breath, it is biological monitoring; if it mentions aggregate trends or sentinel events, it is surveillance.
2. Memorize the triggers. The most common trigger is exposure at or above the action level (usually half the PEL) for 30 or more days per year. Noise is the exception: the action level is 85 dBA TWA and the trigger is reaching it on any basis, not a day count. Respirator medical evaluation is triggered by required respirator use, not by air concentration.
3. Know the numbers that recur. Records: medical records kept employment plus 30 years; exposure records 30 years; audiometric records duration of employment; noise exposure measurements 2 years. Audiometry: baseline within 6 months, 14 hours quiet, STS is 10 dB average at 2000, 3000, 4000 Hz. Lead: action level 30, PEL 50 micrograms per cubic meter; removal at 60 micrograms per deciliter (general industry) or 50 (construction); return below 40. Hepatitis B vaccine offered within 10 working days. Silica exams every 3 years. Employee access to records within 15 working days.
4. Remember what the employer may and may not learn. The correct answer about the PLHCP written opinion always limits disclosure to occupationally relevant findings and work restrictions. Any answer choice in which the employer receives specific unrelated diagnoses is wrong.
5. Surveillance is not a control. If a question asks for the best way to reduce exposure or protect workers, medical surveillance is a distractor. Surveillance evaluates effectiveness; it does not reduce exposure. Choose engineering controls, substitution, or elimination for prevention questions.
6. Understand the purpose of each exam type. Baseline establishes a comparison point and documents pre-existing conditions (and protects the employer from liability for prior conditions). Periodic exams detect change. Termination exams document end-of-exposure status. Event-triggered exams respond to overexposures or symptoms.
7. Recognize marker types. Blood lead is a marker of exposure; zinc protoporphyrin is a marker of effect; cholinesterase depression is a marker of effect; beta-2 microglobulin indicates kidney damage from cadmium. A 4000 Hz audiometric notch indicates noise-induced hearing loss.
8. Apply sensitivity and specificity correctly. Sensitivity relates to detecting true cases (avoiding false negatives); specificity relates to correctly identifying those without disease (avoiding false positives). When a question asks which characteristic is most important for a screening test used to detect a serious but treatable disease, sensitivity is usually the priority.
9. Identify the correct standard. Questions may describe a scenario (welders cutting stainless steel, abrasive blasters, hospital workers with needlesticks, battery plant workers) and ask about surveillance requirements. Map the scenario to the substance: stainless steel welding to hexavalent chromium, blasting to silica, needlesticks to bloodborne pathogens, batteries to lead. Then apply that standard's rules.
10. Watch for absolute language. Choices stating that surveillance is required for all employees, that results must be shared with supervisors, or that employees may be charged for exams are almost always incorrect. Exams are at no cost, at a reasonable time and place, and offered to those who meet the exposure trigger.
11. Connect surveillance findings to action. When a scenario describes abnormal surveillance results (rising blood leads, several STS cases, declining spirometry), the best next step is to investigate exposure controls, reassess monitoring, and implement MRP where required, not simply to repeat the test or counsel the individual alone.
12. Use process of elimination with the program structure. Nearly every OSHA substance-specific standard follows the same skeleton: trigger, baseline exam, periodic exam, event exam, termination exam, PLHCP written opinion, employee notification, recordkeeping. If an answer choice does not fit this skeleton, it is likely the distractor.

Quick Review Summary
Medical surveillance is the systematic health monitoring of exposed workers to detect early effects and verify that controls work. It is secondary prevention, population-oriented, and legally required by many OSHA standards with specific triggers (action level, 30 days per year, required respirator use, 85 dBA). Programs include baseline, periodic, event-driven, and termination exams; biological monitoring compared to BEIs; a confidential PLHCP written opinion limited to work-related findings; medical removal protection where specified; and records retained for the duration of employment plus 30 years. On the exam, classify the concept, apply the numeric triggers, respect confidentiality rules, and never select surveillance as a method of exposure control.